Orthalign
Aliso Viejo, US · Founded 2009 · Delaware corporation · 132 employees on LinkedIn · 4 known investors
Find your way into Orthalign
74 people in our graph share verified history with the Orthalign team — schools, employers, funds. One of them is your warm intro.
OrthAlign develops medical device technology for precise alignment during hip and knee replacement surgery, serving orthopedic surgeons in the surgical technology space.
Also known as OrthAlign · OrthAlign, Inc.
Founders & leadership
Orthalign was founded in 2009 by Jamy Gannoe.
Board
Investors · 4
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$37.2M disclosed across 4 rounds · 2014–2020
▶$11.2MraisedSep 2020 · 6 investors · Other Health CareRule 506(b)
- Gary HenleyDirector
- Wayne WallaceDirector
- Christopher MartinDirector
- Mike BushackExecutive Officer
- D. Ronald YagodaDirector
- Carter McNabbDirector
- William HannaDirector
- Eric TimkoExecutive Officer, Director
- David S. SmithExecutive Officer
- Offering amount
- $18M
- Amount sold
- $11.2M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.2MraisedJan 2020 · 6 investors · Other Health CareRule 506(b)
- Wayne WallaceDirector
- William HannaDirector
- Gary HenleyDirector
- David S. SmithExecutive Officer
- Mike BushackExecutive Officer
- Christopher MartinDirector
- Carter McNabbDirector
- Eric TimkoExecutive Officer, Director
- D. Ronald YagodaDirector
- Offering amount
- $8M
- Amount sold
- $3.2M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.6MraisedAug 2017 · 6 investors · Other Health CareRule 506(b)
- Christopher MartinDirector
- D. Ronald YagodaDirector
- William HannaDirector
- Eric TimkoExecutive Officer, Director
- Wayne WallaceDirector
- Gary HenleyDirector
- David S. SmithExecutive Officer
- Carter McNabbDirector
- Offering amount
- $10M
- Amount sold
- $7.6M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.2MraisedNov 2014 · 15 investors · Other Health CareRule 506(b)
- Christopher MartinDirector
- D. Ronald YagodaDirector
- William HannaDirector
- Carter McNabbDirector
- William E. MayaExecutive Officer, Director
- Wayne WallaceDirector
- Offering amount
- $18.2M
- Amount sold
- $15.2M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026OrthAlign, Inc. is a medical device company that develops handheld, imageless surgical navigation technology used in total joint arthroplasty. Its product line covers total hip, total knee, revision knee and partial knee replacement and includes the Lantern platform (Lantern Hip and Lantern Knee) alongside earlier systems marketed as OrthAlign Plus, HipAlign, KneeAlign and UniAlign. The KneeAlign device provides both tibial and femoral navigation in a palm-sized, single-use form factor compatible with all implant systems, and OrthAlign Plus, introduced for total hip arthroplasty, allows surgeons to position the acetabular cup and measure leg length and offset.
Lantern Hip is designed to deliver real-time guidance for implant positioning and leg length restoration. It launched in 2023 for the supine patient position; in December 2025 the company announced software support for posterior-based approaches and the lateral patient position, with full commercial availability stated for early 2026. In the lateral position the system supports personalization of cup position in the coronal plane with live pelvic tracking; in the supine position it compares cup position across the Anterior Pelvic Plane and Functional Pelvic Plane and measures change in offset. The company also received FDA 510(k) clearance for the Lantern ASC system and has announced first clinical cases with it.
The company positions its systems for use in both hospitals and ambulatory surgery centers (ASCs), citing a capital-free commercial model, portable hardware and compatibility with most implant systems as alternatives to large-footprint robotic platforms. OrthAlign's offices are listed at 153 Technology Drive, Suite 100, Irvine, California, and its site provides a surgeon finder tool for patients.
Business model
OrthAlign sells and places surgical navigation devices and instrumentation used by orthopedic surgeons in hospitals and ambulatory surgery centers. Company materials describe Lantern Hip as offered under a capital-free model, contrasted with capital-intensive robotic systems, and the KneeAlign device is described as a single-use, palm-sized unit compatible with all implant systems.
Revenue derives from sales of navigation devices, single-use handheld units and associated instrumentation to hospitals, ambulatory surgery centers and distributors, offered without upfront capital equipment purchase for the Lantern Hip platform.
Traction
As of the November 2014 financing announcement, the KneeAlign device had been used in more than 21,000 cases worldwide. More recently the company reported FDA 510(k) clearance and first clinical cases for the Lantern ASC system, and the first case using the new lateral Lantern Hip workflow was completed on December 16, 2025 by John McLaughlin, DO, at the Cleveland Clinic.
Latest developments
On December 16, 2025, OrthAlign announced software expanding the Lantern Hip platform to posterior-based surgical approaches and the lateral patient position, with full commercial availability expected by early 2026; the first case with the lateral workflow was performed the same day at the Cleveland Clinic. The company has also announced FDA 510(k) clearance for the Lantern ASC system and the first clinical cases using it.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
The company describes itself as a global player in surgical navigation and a pioneer of handheld orthopedic navigation, positioning its portable, capital-free systems as an accessible alternative to large-footprint surgical robots for hospitals and ASCs.
OrthAlign emphasizes handheld, imageless navigation that avoids the capital cost and physical footprint of robotic systems, works with most implant systems and surgical approaches rather than restricting surgeons to a single vendor's implants, and supports both anterior and posterior-based hip approaches in either supine or lateral patient positioning.
Technology
The company's technology is handheld, imageless computer-assisted surgical navigation for joint replacement. Devices provide real-time intraoperative guidance for implant positioning, including tibial and femoral navigation for knee procedures and acetabular cup positioning, leg length and offset measurement for hip procedures. The Lantern Hip software supports both supine and lateral patient positioning, offering live pelvic tracking and comparison of cup position across the Anterior Pelvic Plane and Functional Pelvic Plane. Instrumentation is described as compatible with most implant systems and surgical approaches.
Go-to-market
OrthAlign reaches customers through direct sales and marketing as well as international distributors; a 2014 financing was earmarked in part for expanding sales and marketing activities and international distributor coverage. The company also publicizes clinical milestones and regulatory clearances through press releases and maintains a public surgeon finder directing patients to clinicians using its technology.
Orthopedic surgeons performing total hip, total knee, revision knee and partial knee arthroplasty, along with the hospitals, ambulatory surgery centers and distributors that serve them.
Geography
U.S.-based with offices in Irvine, California; the company describes itself as a global surgical navigation business and has pursued international distributor expansion, noting that products may not be approved in all areas.
History
OrthAlign commercialized handheld alignment technology beginning with KneeAlign for knee arthroplasty. In November 2014, while based in Aliso Viejo, California, it raised $15 million to launch the OrthAlign Plus hip product, which became commercially available in early 2015, and to expand sales, marketing and international distribution. The company later introduced the Lantern platform, launching Lantern Hip for the supine position in 2023, obtaining FDA 510(k) clearance for the Lantern ASC system, and expanding Lantern Hip to posterior-based and lateral approaches in December 2025. Its listed address is now in Irvine, California.
Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 6
by search overlap
Companies competing with Orthalign for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 6
launches, deals, and filingsOrthAlign announced new software extending Lantern Hip to posterior-based surgical approaches and the lateral patient position, with full commercial availability expected by early 2026. The first clinical case with the lateral workflow was performed by John McLaughlin, DO, at the Cleveland Clinic.
OrthAlign announced completion of the first clinical cases using the Lantern ASC system.
OrthAlign announced FDA 510(k) clearance for the Lantern ASC system.
Lantern Hip, a handheld imageless navigation platform for total hip arthroplasty, initially launched for the supine patient position.
OrthAlign Plus, a handheld navigation technology for total hip arthroplasty enabling acetabular cup positioning and measurement of leg length and offset, was stated to be commercially available in early 2015.
OrthAlign announced a $15.0 million preferred series capital raise led by existing investors River Cities Capital Funds and Mutual Capital Partners, to fund the OrthAlign Plus launch, sales and marketing expansion, and international market growth.
$15M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structure▸Research sources · 6
primary sources listed
- Orthalignorthalign.com · web
6 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Orthalign do?
- OrthAlign makes handheld, imageless surgical navigation systems for hip and knee joint replacement procedures.
- Who founded Orthalign?
- Orthalign was founded by Jamy Gannoe in 2009.
- Who are Orthalign's investors?
- Orthalign's investors include California Technology Ventures, Mutual Capital Partners, RC Capital.
- How much funding has Orthalign raised?
- Orthalign has disclosed $37.2M raised across 4 rounds.
- Where is Orthalign headquartered?
- Orthalign is headquartered in Aliso Viejo, US.